Ishita Drugs & Industries Ltd.
BSE: 524400 | Sector: Health care |
NSE: N.A. | ISIN Code: INE806D01016 |
BSE 00:00 | 06 Feb | 49.45 |
-2.50 (-4.81%) |
OPEN
54.95 |
HIGH
54.95 |
LOW
48.50 |
NSE 05:30 | 01 Jan | Ishita Drugs & Industries Ltd |
OPEN | 54.95 |
PREVIOUS CLOSE | 51.95 |
VOLUME | 558 |
52-Week high | 79.55 |
52-Week low | 36.10 |
P/E | 18.18 |
Mkt Cap.(Rs cr) | 15 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Ishita Drugs & Industries Ltd. (ISHITADRUGS) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 1023.50 | -4.15 | -0.40 | 15585.98 |
Dr Reddy's Labs | 4350.05 | -7.85 | -0.18 | 14405.20 |
Cipla | 1029.75 | 6.75 | 0.66 | 13091.79 |
Lupin | 745.05 | 5.55 | 0.75 | 11771.67 |
Aurobindo Pharma | 415.45 | 11.55 | 2.86 | 11287.14 |
Divi's Lab. | 2778.15 | -106.30 | -3.69 | 8879.82 |
Alkem Lab | 3069.25 | 16.65 | 0.55 | 8829.81 |
Glenmark Pharma. | 399.20 | 13.40 | 3.47 | 8141.58 |
Zydus Lifesci. | 470.15 | 36.15 | 8.33 | 7981.90 |
Torrent Pharma. | 1539.80 | 7.60 | 0.50 | 6742.32 |
Apollo Hospitals | 4317.25 | 72.50 | 1.71 | 6098.30 |
Ipca Labs. | 858.75 | 3.25 | 0.38 | 5399.36 |
Alembic Pharma | 527.95 | -7.30 | -1.36 | 5035.41 |
Abbott India | 20881.35 | 13.80 | 0.07 | 4919.27 |
Laurus Labs | 334.10 | 2.90 | 0.88 | 4707.04 |
Gland Pharma | 1174.10 | -39.20 | -3.23 | 4400.71 |
Granules India | 288.30 | -3.60 | -1.23 | 3238.44 |
Glaxosmi. Pharma | 1238.50 | -6.50 | -0.52 | 3217.51 |
Ajanta Pharma | 1164.05 | -11.10 | -0.94 | 3140.64 |
Piramal Pharma | 100.45 | -0.15 | -0.15 | 3094.95 |
Quick Links for Ishita Drugs & Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices